Standard BioTools Inc.
LAB
$1.01
$0.000.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 21.15M | 23.80M | 19.55M | 21.76M | 20.22M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.15M | 23.80M | 19.55M | 21.76M | 20.22M |
| Cost of Revenue | 11.79M | 12.41M | 10.07M | 11.13M | 14.27M |
| Gross Profit | 9.35M | 11.38M | 9.48M | 10.63M | 5.95M |
| SG&A Expenses | 18.61M | 25.34M | 26.60M | 28.11M | 29.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.56M | 45.72M | 43.02M | 45.46M | 44.44M |
| Operating Income | -9.42M | -21.92M | -23.47M | -23.70M | -24.22M |
| Income Before Tax | -14.62M | -22.03M | -32.90M | -18.28M | -23.49M |
| Income Tax Expenses | 11.00K | -35.93M | -1.22M | -609.00K | -119.00K |
| Earnings from Continuing Operations | -14.63M | 13.90M | -31.68M | -17.67M | -23.37M |
| Earnings from Discontinued Operations | 141.69M | 5.38M | -3.00M | -15.79M | -2.66M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 127.07M | 19.28M | -34.69M | -33.46M | -26.03M |
| EBIT | -9.42M | -21.92M | -23.47M | -23.70M | -24.22M |
| EBITDA | -8.01M | -16.64M | -21.87M | -19.71M | -22.13M |
| EPS Basic | 0.33 | 0.05 | -0.09 | -0.09 | -0.07 |
| Normalized Basic EPS | -0.01 | -0.02 | -0.04 | -0.03 | -0.04 |
| EPS Diluted | 0.33 | 0.05 | -0.09 | -0.09 | -0.07 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.04 | -0.03 | -0.04 |
| Average Basic Shares Outstanding | 388.20M | 385.05M | 382.63M | 380.50M | 378.23M |
| Average Diluted Shares Outstanding | 388.20M | 385.05M | 382.63M | 380.50M | 378.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |